Sharecare’s SPAC confirmed, BrainQ’s Breakthrough Device Designation and more digital health news briefs

Posted on

SPAC rumors pan out. Only just a few weeks after rumors unfold of Sharecare’s upcoming merger with a selected operate acquisition agency (SPAC), the patient-engagement and benefits-navigation platform made it official with an announcement on Friday.

Sharecare will most likely be merging with Falcon Capital Acquisition and itemizing on NASDAQ. The deal is about to be funded by the use of $345 million in cash in perception from Falcon and supported by a $425 million private funding in public equity and a direct funding from Anthem, which will most likely be partnering with the combined entity.

This deal will go away the company with about $400 million in improvement capital, in accordance with the announcement, and an entire enterprise value of $3.9 billion.

HIMSS20 Digital

Study on-demand, earn credit score rating, uncover merchandise and choices. Get Began >>

“We began Sharecare to leverage improvements in client expertise – particularly the smartphone – to create a frictionless expertise that engages folks throughout the dynamic continuum of their healthcare wants,” Jeff Arnold, who will proceed his place as founder, chairman and CEO of Sharecare, said in a press launch. “By integrating fragmented level options and bringing collectively stakeholders throughout the healthcare ecosystem into one related digital care platform, we consider that Sharecare is uniquely positioned to rework the way in which folks entry, suppliers ship, and employers and well being plans administer prime quality, value environment friendly healthcare.”

Breakthrough Designation for stroke restoration treatment gadget. BrainQ, an Israeli agency that makes use of AI to ship electromagnetic space treatment to stroke victims by the use of a wearable gadget, launched closing week that its system has obtained Breakthrough System Designation from the FDA. The firm’s dedication was based mostly totally on a present randomized managed trial carried out amongst ischemic stroke victims, which the company said will most likely be launched publicly subsequent month on the American Coronary coronary heart Affiliation’s annual Worldwide Stroke Convention.

“Stroke is a debilitating situation with restricted restoration choices, creating an enormous unmet want within the US,” Yotam Drechsler, CEO and cofounder of BrainQ, said in a press launch. “COVID-19 has solely made issues worse by limiting sufferers’ entry to remedy services. FDA Breakthrough Designation is a crucial milestone in our mission to cut back incapacity for these sufferers and deal with them within the consolation of their properties.”

App will help look at COVID-19 vaccinations in Germany. docdok.effectively being, a Swiss-Israeli startup offering a healthcare communications platform connecting professions and victims, launched yesterday a partnership with German specialist umbrella group the Nationwide Affiliation of Specialists in Germany (SpiFa) and its German Institute for Specialist Well being Companies Analysis (DIFA) on an app-based problem to doc the safety and effectiveness of COVID-19 vaccination.

The companions will distribute a docdok-built look at app to the group’s 160,000 healthcare provider members as they get hold of their COVID-19 vaccination. The app will request associated data regarding unintended results and completely different areas of curiosity over 12 months, information that may then be transferred to DIFA for look at.

“With the anticipated outcomes, we are able to hopefully dispel current reservations amongst the inhabitants and obtain wider acceptance of the vaccination,” Dr. Yves Nordmann, cofounder and chief medical officer of docdok.well being, stated in a press release. “After launching comparable initiatives in different international locations, we’re hopeful that by launching DIFA1 app along with our companions SpiFa and DIFA, we are going to make a useful contribution to the combat in opposition to the coronavirus.”

Watson, what are my effectively being benefits? IBM Watson Well being and Humana have teamed as much as make use of the earlier’s conversational AI experience as a digital assistant to help the payer’s Employer Group members larger understand their benefits. Introduced closing week, the affiliation will see the cloud-based IBM Watson Assistant for Well being Advantages deployed to 1.3 million medical and 1.8 million dental members off the bat. Consequently, the digital assistant can be able to instantly reply members’ questions whereas serving to launch Humana’s employees and identify center personnel.

“Navigating our well being protection with out the proper assist can probably function a barrier to care,” Paul Roma, frequent supervisor at IBM Watson Well being, said in a press launch. “An AI-enabled conversational agent that’s educated to know well being plan advantages logic can play a task in serving to to simplify advanced or probably complicated plan info.”

Leave a Reply

Your email address will not be published. Required fields are marked *